Metformin: Multi-faceted protection against cancer

@inproceedings{Barco2011MetforminMP,
  title={Metformin: Multi-faceted protection against cancer},
  author={S{\`o}nia Del Barco and Alejandro V{\'a}zquez-Mart{\'i}n and S{\'i}lvia Cuf{\'i} and Cristina Oliveras-Ferraros and Joaquim Bosch-Barrera and Jorge Joven and Bego{\~n}a Mart{\'i}n-Castillo and Javier A. Men{\'e}ndez},
  booktitle={Oncotarget},
  year={2011}
}
The biguanide metformin, a widely used drug for the treatment of type 2 diabetes, may exert cancer chemopreventive effects by suppressing the transformative and hyperproliferative processes that initiate carcinogenesis. Metformin's molecular targets in cancer cells (e.g., mTOR, HER2) are similar to those currently being used for directed cancer therapy. However, metformin is nontoxic and might be extremely useful for enhancing treatment efficacy of mechanism-based and biologically targeted… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 109 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 204 references

Similar Papers

Loading similar papers…